An extended course of antibiotics showed no short-term clinical benefit for children hospitalized with community-acquired pneumonia compared with a standard, shorter course, a study found.
The study was conducted by researchers in Australia, Malaysia, New Zealand and Singapore and published in The Pediatric Infectious Disease Journal.
The researchers noted that high-level evidence was limited for antibiotic duration among children from First Nations and different at-risk populations who had been hospitalized with community-acquired pneumonia (CAP).
“Despite its large disease burden,